To more accurately predict prognosis in patients with CN-AML, ACTL10 RNA expression levels and ACTL10 DNA methylation levels were combined in 74 patients with CN-AML; the results were found to be consistent with the previous results. The gene discussed is ACTL10; the disease is acute myeloid leukemia.